About SensArs
SensArs is a company based in Saint-sulpice (Switzerland) founded in 2014 by Francesco Maria Petrini and Stanisa Raspopovic. SensArs has raised $184.89 thousand across 9 funding rounds from investors including European Commission, EIT Health and European Union. SensArs offers products and services including SENSY and Neuroprosthetic System. SensArs operates in a competitive market with competitors including Össur, WeWALK, BionicM, REEV and Instalimb, among others.
- Headquarter Saint-sulpice, Switzerland
- Founders Francesco Maria Petrini, Stanisa Raspopovic
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$184.89 K (USD)
in 9 rounds
-
Latest Funding Round
$1.83 M (USD), Grant
Nov 01, 2019
-
Investors
European Commission
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SensArs
SensArs offers a comprehensive portfolio of products and services, including SENSY and Neuroprosthetic System.
Restores sensory feedback in limbs for diabetic neuropathy patients via implants.
Enhances sensory capabilities in bionic limbs through advanced technology.
People of SensArs
Unlock access to complete
Unlock access to complete
Funding Insights of SensArs
SensArs has successfully raised a total of $184.89K across 9 strategic funding rounds. The most recent funding activity was a Grant round of $1.83 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SensArs
SensArs has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Commission, EIT Health and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
University backed startup accelerator
|
Locked | Locked | Locked |
Investor details for SensArs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SensArs
Investment portfolio details for SensArs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SensArs
Detailed financials for SensArs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sensars Comparisons
Peer comparison for SensArs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SensArs
SensArs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Össur, WeWALK, BionicM, REEV and Instalimb, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Orthopedic bracing and support products are developed and sold.
|
|
| Locked | Locked | Locked |
Smart cane solutions are provided for visually impaired users.
|
|
| Locked | Locked | Locked |
Prosthetic legs assisting knee and ankle movements are developed.
|
|
| Locked | Locked | Locked |
AI-powered exoskeletons and gait tools are developed for mobility recovery.
|
|
| Locked | Locked | Locked |
Customized 3D-printed prosthetics for leg amputees are developed.
|
Detailed competitors of SensArs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sensars
Complete news archive for SensArs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SensArs
SensArs was founded in 2014 and raised its 1st funding round 3 years after it was founded.
SensArs is headquartered in Saint-sulpice, Switzerland. It is registered at Saint-sulpice, Vaud, Switzerland.
Francesco Maria Petrini is the current CEO of SensArs. They have also founded this company.
SensArs is a funded company, having raised a total of $184.89K across 9 funding rounds to date.
SensArs Neuroprosthetics was founded in 2014 in Saint Sulpice, Switzerland, within the neuroprosthetics sector. A hybrid device named SENSY is being developed, featuring an intraneural electrode for sensory nerve stimulation. The electrode is implanted in residual or healthy nerve parts to restore natural-like neural sensory information flow. Sensations from missing or non-functional limbs are thereby enabled in users, supporting improved functionality in prosthetic applications.
SensArs offers SENSY and Neuroprosthetic System.
SensArs has 5 investors. Key investors include European Commission, EIT Health, European Union, EIC Fund, and Venture Kick.